TriplePoint Venture Growth BDC Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TriplePoint Venture Growth BDC Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $49.21M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $32.05M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | ($39.82M) | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | ($20.07M) | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $76.56M | Mar 6, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($57.03M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $152.92M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $106.15M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | ($100.89M) | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | ($144.68M) | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | $63.67M | Mar 1, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $839.65M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $763.04M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $978.83M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $1.01B | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $927.67M | Mar 1, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $486.03M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $417.35M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $632.52M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $594.59M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $493.18M | Mar 1, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $353.62M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $345.69M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $346.31M | Mar 4, 2026 |
| FY2025 | Dec 31, 2022 | $419.94M | Mar 4, 2026 |
| FY2025 | Dec 31, 2021 | $434.49M | Mar 4, 2026 |
| FY2025 | Dec 31, 2020 | $400.44M | Mar 4, 2026 |
| FY2024 | Dec 31, 2019 | $332.51M | Mar 5, 2025 |
| FY2023 | Dec 31, 2018 | $334.53M | Mar 6, 2024 |
| FY2022 | Dec 31, 2017 | $234.95M | Mar 1, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($161.18M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | ($168.43M) | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | ($147.00M) | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | ($50.99M) | Mar 6, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.36M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $45.90M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $153.33M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $51.49M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $51.27M | Mar 6, 2024 |
| FY2022 | Dec 31, 2020 | $38.22M | Mar 1, 2023 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $464.44M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $394.92M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $605.18M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $562.85M | Mar 6, 2024 |
| FY2022 | Dec 31, 2021 | $465.33M | Mar 1, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Mar 4, 2026 |
| FY2022 | Dec 31, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Sep 30, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Jun 30, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Mar 31, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 1, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Mar 1, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Mar 1, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Mar 4, 2026 |
| FY2022 | Dec 31, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Sep 30, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Jun 30, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Mar 31, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 1, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Mar 1, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Mar 1, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 40.49M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | 40.14M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | 37.62M | Mar 4, 2026 |
| FY2025 | Dec 31, 2022 | 35.35M | Mar 4, 2026 |
| FY2025 | Dec 31, 2021 | 31.01M | Mar 4, 2026 |
| FY2024 | Dec 31, 2020 | 30.87M | Mar 5, 2025 |
| FY2023 | Dec 31, 2019 | 24.92M | Mar 6, 2024 |
| FY2022 | Dec 31, 2018 | 24.78M | Mar 1, 2023 |